Form 8-K - Current report:
SEC Accession No. 0001437749-22-000218
Filing Date
2022-01-04
Accepted
2022-01-04 06:02:01
Documents
64
Period of Report
2022-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20220102_8k.htm   iXBRL 8-K 81218
2 EXHIBIT 4.1 ex_321035.htm EX-4.1 109859
3 EXHIBIT 10.1 ex_321036.htm EX-10.1 90344
4 EXHIBIT 99.1 ex_321157.htm EX-99.1 10543
5 EXHIBIT 99.2 ex_321158.htm EX-99.2 28429
10 ex_321157img001.gif GRAPHIC 2128
11 slide01.jpg GRAPHIC 121992
12 slide02.jpg GRAPHIC 202445
13 slide03.jpg GRAPHIC 151127
14 slide04.jpg GRAPHIC 131171
15 slide05.jpg GRAPHIC 104062
16 slide06.jpg GRAPHIC 141084
17 slide07.jpg GRAPHIC 113862
18 slide08.jpg GRAPHIC 137414
19 slide09.jpg GRAPHIC 122585
20 slide10.jpg GRAPHIC 114013
21 slide11.jpg GRAPHIC 137237
22 slide12.jpg GRAPHIC 143311
23 slide13.jpg GRAPHIC 140695
24 slide14.jpg GRAPHIC 145588
25 slide15.jpg GRAPHIC 132372
26 slide16.jpg GRAPHIC 160276
27 slide17.jpg GRAPHIC 137299
28 slide18.jpg GRAPHIC 135119
29 slide19.jpg GRAPHIC 162154
30 slide20.jpg GRAPHIC 113239
31 slide21.jpg GRAPHIC 134652
32 slide22.jpg GRAPHIC 136815
33 slide23.jpg GRAPHIC 143805
34 slide24.jpg GRAPHIC 101982
35 slide25.jpg GRAPHIC 150090
36 slide26.jpg GRAPHIC 167952
37 slide27.jpg GRAPHIC 132638
38 slide28.jpg GRAPHIC 147407
39 slide29.jpg GRAPHIC 124268
40 slide30.jpg GRAPHIC 103610
41 slide31.jpg GRAPHIC 145279
42 slide32.jpg GRAPHIC 118842
43 slide33.jpg GRAPHIC 128973
44 slide34.jpg GRAPHIC 89713
45 slide35.jpg GRAPHIC 72907
46 slide36.jpg GRAPHIC 113879
47 slide37.jpg GRAPHIC 151151
48 slide38.jpg GRAPHIC 32225
49 slide39.jpg GRAPHIC 126131
50 slide40.jpg GRAPHIC 121860
51 slide41.jpg GRAPHIC 140306
52 slide42.jpg GRAPHIC 101747
53 slide43.jpg GRAPHIC 134774
54 slide44.jpg GRAPHIC 146656
55 slide45.jpg GRAPHIC 144161
56 slide46.jpg GRAPHIC 121982
  Complete submission text file 0001437749-22-000218.txt   8758009

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20220103.xsd EX-101.SCH 3592
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220103_def.xml EX-101.DEF 11806
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220103_lab.xml EX-101.LAB 15857
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220103_pre.xml EX-101.PRE 12021
58 EXTRACTED XBRL INSTANCE DOCUMENT arav20220102_8k_htm.xml XML 2653
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 22503961
SIC: 2834 Pharmaceutical Preparations